10-K
Annual Report
VITASPRING BIOMEDICAL CO., LTD.
CIK: 1697884
File #: 333-216645
Balance Sheet
38 line items · 2 periods
XBRL
| Item | Jan 31, 2023 | Jan 31, 2022 |
|---|---|---|
CONSOLIDATED BALANCE SHEETS | ||
ASSETS | ||
CURRENT ASSETS | ||
Cash and cash equivalents | 29,656 | 107,212 |
Accounts Receivable | 380,000 | 2,952,022 |
Other Non-Operating Current Assets | 27,422 | 2,634 |
Total current assets | 437,078 | 3,061,868 |
LONG-TERM ASSETS | ||
Property, Plant and Equipment | 49,574 | 64,636 |
Operating Lease Right-of-Use Asset | 255,682 | 459,955 |
Other Non-Current Assets | 23,614 | 17,614 |
Total long-term assets | 328,870 | 542,205 |
Total assets | 765,948 | 3,604,073 |
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||
CURRENT LIABILITIES | ||
Accounts payable | 2,411,000 | 1,251,500 |
Taxes Payable | 218,714 | 210,923 |
Operating Lease Liability, Current | 169,647 | 181,103 |
Other Non-Operating Current Liabilities | 55,063 | 0 |
Advances from related party | 214,682 | 94,358 |
Total current liabilities | 3,069,106 | 1,737,884 |
Operating Lease Liability, Non-Current | 93,334 | 282,469 |
Deferred Tax Liabilities, Current | 0 | 6,181 |
Total long-term liabilities | 93,334 | 288,650 |
Total liabilities | 3,162,440 | 2,026,534 |
COMMITMENTS AND CONTINGENCIES | 0 | 0 |
STOCKHOLDERS' EQUITY | ||
Total Stockholders' Equity | 20,703 | 20,652 |
Effect Of Restatement | — | 0 |
As Previously Reported | — | 20,652 |
Total Stockholders' Equity | 970,824 | 780,510 |
Effect Of Restatement | — | (97,287) |
As Previously Reported | — | 877,797 |
Retained Earnings (Deficit) | (3,388,019) | 776,377 |
Effect Of Restatement | — | (40,347) |
As Previously Reported | — | 816,724 |
Total stockholders' (deficit)/equity | (2,396,492) | 1,577,539 |
Total liabilities and stockholders' equity | 765,948 | 3,604,073 |